Boxer Capital’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-696,480
| Closed | -$20.5M | – | 54 |
|
|
2024
Q3 | $20.5M | Hold |
696,480
| – | – | 1.01% | 27 |
|
|
2024
Q2 | $16.4M | Buy |
696,480
+446,480
| +179% | +$10.5M | 0.86% | 31 |
|
|
2024
Q1 | $9.48M | Hold |
250,000
| – | – | 0.47% | 45 |
|
|
2023
Q4 | $5.38M | Buy |
+250,000
| New | +$5.38M | 0.27% | 40 |
|
|
2021
Q3 | – | Sell |
-22,000
| Closed | -$3.83M | – | 100 |
|
|
2021
Q2 | $3.83M | Hold |
22,000
| – | – | 0.14% | 83 |
|
|
2021
Q1 | $4.36M | Hold |
22,000
| – | – | 0.15% | 74 |
|
|
2020
Q4 | $4.33M | Hold |
22,000
| – | – | 0.14% | 71 |
|
|
2020
Q3 | $3.9M | Hold |
22,000
| – | – | 0.13% | 69 |
|
|
2020
Q2 | $5.09M | Buy |
+22,000
| New | +$5.09M | 0.22% | 58 |
|